Much ado about something: a response to “COVID-19: underpowered randomised trials, or no randomised trials?”
Abstract Non-pharmaceutical interventions (NPI) for infectious diseases such as COVID-19 are particularly challenging given the complexities of what is both practical and ethical to randomize. We are often faced with the difficult decision between having weak trials or not having a trial at all. In...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
BMC
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/acc80c986e95464cbc126642a8ed9314 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|